期刊文献+

原发性肝癌组织中芳香化酶和存活素的表达及其临床病理意义 被引量:3

Expression of Aromatase and survivin and Their Clinicopathologic Significance in Primary Hepatocarcinoma
下载PDF
导出
摘要 目的研究芳香化酶(aromatase,Arom)和存活素(survivin,Surv)在原发性肝癌(primary hepatocarcinoma,PHC)中的表达情况,探讨它们间的相互关系以及与PHC临床病理特征之间的关系。方法应用ABC免疫组化染色法对47例PHC手术切除标本切片分别检测Arom和Surv的表达,并于高倍镜下评分。结果47例PHC癌组织中Arom和Surv的表达阳性率和表达评分均显著高于癌旁组织:Arom,40.43%vs21.38%(P<0.05),1.53±1.69vs0.79±1.41(P<0.05);Surv,63.83%vs31.91%(P<0.01),2.40±1.96vs1.45±1.80(P<0.05)。除Surv在肿块最大径<5cm的癌组织中的表达评分(4.00±2.10)显著高于肿块最大径≥5cm者(2.17±1.86)外(P<0.05),Arom和Surv在PHC中的表达情况与PHC其他主要临床病理特征之间均无明显关系;癌组织中Arom与Surv的表达评分呈正相关(r=0.316,P<0.05)。结论Arom和Surv的表达在PHC发生、发展中可能有着密切的关系。 Objective To investigate the expressions of aromatase (Arom) and survivin (Surv) in primary hepatocarcinoma(PHC), and explore their relationships with the clinicopathology of PHC. Methods The specimens from 47 patients with PHC were fixed in 10% formalin and routinely embedded in paraffin. The specimens were continuously sliced into 4 μm-thick sections. ABC immunohistochemistry was performed to detect the expressions of Arom and Surv with polyclonal antibodies and scored them under high-power microscopy. Results The positive rates and the scores of Arom and Surv in cancer tissues were significantly higher than those of the para- tumor tissues [Arom: 40.43% vs 21.28% (P〈0.05), 1.53± 1.69 vs0.79±1.41 (P〈0.05); Surv: 63.83% vs 31.91% (P〈0.01), 2.40± 1.96 vs 1.45± 1.80 (P〈0.05)3. The score of Surv in tumors with the maximal diameter 〈5 cm (4. 00 ± 2. 10) was significantly higher than that in tumors with the maximal diameter ≥ 5 cm (2.17±1.86), P〈0.05. However, there was no relationship between the expressions of Arom and Surv in PHCs and other clinicopathologic features of the PHCs. The positive correlation was found between the score of Arom and that of Surv in PHCs (r=0. 316,P〈0.05). Conclusion The expressions of Arom and Surv might be closely related to the carcinogenesis and development of PHC.
出处 《中国普外基础与临床杂志》 CAS 2006年第3期321-324,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 原发性肝癌 芳香化酶 存活素 免疫组织化学 Primary hepatocarcinoma Aromatase survivin Immunohistochemistry
  • 相关文献

参考文献10

  • 1Harada N,Ota H,Yoshimura N,et al.Localized aberrant expression of cytochrome P450 aromatase in primary and metastatic malignant tumors of human liver[J].J Clin Endocrinol Metab,1998; 83(2):697.
  • 2Kappler M,Kotzsch M,Bartel F,et al.Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival[J].Clin Cancer Res,2003; 9(3):1098.
  • 3胡淳玲,喻伦银,陈德基,刘铭球,江曼,唐志佼,夏东,刘绚,陈洪雷,李红钢.大鼠实验性肺鳞癌癌变各阶段间质微血管密度及VEGF、FLK-1表达的动态变化[J].癌症,2001,20(7):713-717. 被引量:51
  • 4Meinhardt U,Mullis PE.The aromatase cytochrome P-450 and its clinical impact[J].Horm Res,2002; 57(5-6):145.
  • 5Castagnetta LA,Agostara B,Montalto G,et al.Local estrogen formation by nontumoral,cirrhotic,and malignant human liver tissues and cells[J].Cancer Res,2003; 63(16):5041.
  • 6Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7[J].Biochemistry,2001; 40(4):1117.
  • 7林木生,伊新,缪辉来,王三明.生存素和天冬氨酸特异性半胱氨酸蛋白酶-3在肝癌中的表达及其关系[J].中华实验外科杂志,2004,21(2):210-211. 被引量:5
  • 8Shekhar MP,Werdell J,Tait L.Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells:regulation by estrogen[J].Cancer Res,2000;60(2):439.
  • 9Kirma N,Gill K,Mandava U,et al.Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis,cell cycle,growth,and tumor suppressor functions in the mammary glands of transgenic mice[J].Cancer Res,2001; 61(5):1910.
  • 10Thiantanawat A,Long BJ,Brodie AM.Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens[J].Cancer Res,2003; 63(22):8037.

二级参考文献8

  • 1Tian H S,Chin Med J,1984年,97卷,36页
  • 2刘铭球,中华肿瘤杂志,1994年,16卷,269页
  • 3韩铭钧,中华放射学杂志,1988年,22卷,243页
  • 4Salvucci O,Garsana M,Bersani I,et al.Antiapoptotic role of endogenous nitric oxide in human melanoma cells[].Cancer Research.2001
  • 5Ikeguchi M,Ueda T,Sakatani T,et al.Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma[].Diagnostic Molecular Pathology.2002
  • 6Sarela AI,Macadam RC,Farmery SM,et al.Expression of the antiapoptosis gene, survivin predicts death from recurrent colorectal carcinoma[].Gut.2000
  • 7Smith SD,Wheeler MA,Plescia J,et al.Urine detection of survivin and diagnosis of bladder cancer[].The Journal of The American Medical Association.2001
  • 8Ito T,Shiraki K,Sugimoto K,et al.Survivin promtes cell proliferation in human hepatocellular carcinoma[].Hepatology.2000

共引文献54

同被引文献30

  • 1黄赞松,向发良,周喜汉,黄衍强,邓志华,仇仪英.苦参素对肝癌细胞HepG2细胞增殖和MicroRNA-122、MicroRNA-21表达的影响[J].中国老年学杂志,2014,34(11):3079-3081. 被引量:21
  • 2元云飞,李锦清,李斌奎,张亚奇,李国辉.影响肝细胞肝癌切除术后长期生存的相关因素[J].中国实用外科杂志,2004,24(10):608-611. 被引量:9
  • 3赵晓利,李力,郭建新,徐德斌,胡珊,陈竹钦.顺铂诱导survivin表达改变与宫颈癌细胞化疗敏感性的关系[J].第三军医大学学报,2005,27(10):1023-1025. 被引量:6
  • 4叶超平,邱成志,黄种心,庄伟,吴瑞兰,李新丰.肝癌术后复发及预后与Survivin表达的关系[J].中华实验外科杂志,2006,23(7):829-830. 被引量:9
  • 5Moroy G, Ostuni A, Pepe A, et al. A proposed interaction mechanism between elastin-derived peptides and the elastin/laminin receptor-bind- ing domain [ J ]. Proteins, 2009,76 ( 2 ) :461-476.
  • 6Sofia G, Yaal-Hahoshen N, Azenshtein E, et al. Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer:a ba- sis for tumor-promoting interactions [ J ]. Cytokine, 2008,44 ( 1 ) : 191- 200.
  • 7Charni F, Friand V, Haddad O, et al. Syndecan-1 and syndecan4 are involved in RANTES/CCLS-induced migration and invasion of human hepatoma cells [ J ]. Biochim Biophys Acta, 2009,1790 ( 10 ) : 1314- 1326.
  • 8Hembruff SL, Cheng N. Chemokine signaling in cancer:Implications on the tumor mieroenvironment and therapeutic targeting [ J ]. Cancer T- her,2009,14 (7A) :254-267.
  • 9Lau AC, Duong 33", Ito S, et al. Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease [ J ]. Arthritis Rheum,200g ,58 (3) :854-863.
  • 10Azenshtein E, Luboshits G, Shlna S, et al. The CC chemokine RANTES in breast carcinoma progression : regulation of expression and potential mechanisms of promalignant activity [ J ]. Cancer Res, 2002,62 ( 4 ) : 1093-1102.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部